West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)
Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%
West Pharmaceutical Services total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
West Pharmaceutical Services's total debt was $202.90M at Sep 30, 2026. For fiscal 2025 it was $202.80M, up 0.1% from the year before. Over ten years it grew -3.8% a year on average. The highest annual figure on record is $411.50M in fiscal 2012.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $202.80M | +0.1% |
| FY2024 | Dec 31, 2024 | $202.60M | -2.0% |
| FY2023 | Dec 31, 2023 | $206.80M | -1.0% |
| FY2022 | Dec 31, 2022 | $208.90M | -17.4% |
| FY2021 | Dec 31, 2021 | $253.00M | -0.9% |
| FY2020 | Dec 31, 2020 | $255.20M | -0.8% |
| FY2019 | Dec 31, 2019 | $257.30M | +31.2% |
| FY2018 | Dec 31, 2018 | $196.10M | -0.5% |
| FY2017 | Dec 31, 2017 | $197.00M | -13.8% |
| FY2016 | Dec 31, 2016 | $228.60M | -23.3% |
| FY2015 | Dec 31, 2015 | $298.20M | -11.1% |
| FY2014 | Dec 31, 2014 | $335.50M | -10.2% |
| FY2013 | Dec 31, 2013 | $373.50M | -9.2% |
| FY2012 | Dec 31, 2012 | $411.50M | +17.8% |
| FY2011 | Dec 31, 2011 | $349.40M | -2.5% |
| FY2010 | Dec 31, 2010 | $358.40M | -5.6% |
| FY2009 | Dec 31, 2009 | $379.60M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $202.90M | +0.1% |
| Q2 FY2026 | Jun 30, 2026 | $202.90M | +0.1% |
| Q1 FY2026 | Mar 31, 2026 | $202.80M | +0.1% |
| Q4 FY2025 | Dec 31, 2025 | $202.80M | +0.1% |
| Q3 FY2025 | Sep 30, 2025 | $202.70M | +0.0% |
| Q2 FY2025 | Jun 30, 2025 | $202.60M | -1.6% |
| Q1 FY2025 | Mar 31, 2025 | $202.60M | -1.7% |
| Q4 FY2024 | Dec 31, 2024 | $202.60M | -2.0% |
| Q3 FY2024 | Sep 30, 2024 | $202.60M | -2.3% |
| Q2 FY2024 | Jun 30, 2024 | $205.80M | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | $206.20M | -1.0% |
| Q4 FY2023 | Dec 31, 2023 | $206.80M | -1.0% |
| Q3 FY2023 | Sep 30, 2023 | $207.30M | -1.0% |
| Q2 FY2023 | Jun 30, 2023 | $207.80M | -17.5% |
| Q1 FY2023 | Mar 31, 2023 | $208.30M | -17.5% |
| Q4 FY2022 | Dec 31, 2022 | $208.90M | -17.4% |
| Q3 FY2022 | Sep 30, 2022 | $209.40M | -17.6% |
| Q2 FY2022 | Jun 30, 2022 | $252.00M | -0.8% |
| Q1 FY2022 | Mar 31, 2022 | $252.50M | -0.8% |
| Q4 FY2021 | Dec 31, 2021 | $253.00M | -0.9% |
| Q3 FY2021 | Sep 30, 2021 | $254.10M | -0.6% |
| Q2 FY2021 | Jun 30, 2021 | $254.10M | -0.8% |
| Q1 FY2021 | Mar 31, 2021 | $254.60M | -0.8% |
| Q4 FY2020 | Dec 31, 2020 | $255.20M | -0.8% |
| Q3 FY2020 | Sep 30, 2020 | $255.70M | +31.1% |
| Q2 FY2020 | Jun 30, 2020 | $256.20M | +30.7% |
| Q1 FY2020 | Mar 31, 2020 | $256.70M | +31.3% |
| Q4 FY2019 | Dec 31, 2019 | $257.30M | +31.2% |
| Q3 FY2019 | Sep 30, 2019 | $195.10M | -0.6% |
| Q2 FY2019 | Jun 30, 2019 | $196.00M | -0.2% |
| Q1 FY2019 | Mar 31, 2019 | $195.50M | -1.3% |
| Q4 FY2018 | Dec 31, 2018 | $196.10M | -0.5% |
| Q3 FY2018 | Sep 30, 2018 | $196.20M | -14.6% |
| Q2 FY2018 | Jun 30, 2018 | $196.40M | -14.4% |
| Q1 FY2018 | Mar 31, 2018 | $198.00M | -13.4% |
| Q4 FY2017 | Dec 31, 2017 | $197.00M | -13.8% |
| Q3 FY2017 | Sep 30, 2017 | $229.80M | – |
| Q2 FY2017 | Jun 30, 2017 | $229.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $228.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $228.60M | – |
See a number that looks wrong?